Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Esai Pharmaceuticals
Washington University Early Recognition Center
Wake Forest School of Medicine
University of Chicago
University of North Carolina
Roswell Park Cancer Institute
Weill Medical College of Cornell University
Information provided by (Responsible Party):
Lawrence Kaplan, University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT00632827
First received: February 28, 2008
Last updated: October 3, 2014
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)